DRG Epidemiology’s coverage of BPH comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of BPH in each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years in the major mature pharmaceutical markets and 10 years in the other countries covered in this report.
DRG Epidemiology’s BPH forecast will answer the following question:
All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.
DRG Epidemiology provides at least ten years of forecast data for the following BPH populations:
Note: Coverage may vary by country.